Live feed
Filing
SC 13D
SC 13D0001104659-20-038823·Assertio Therapeutics, Inc
Schedule 13D ownership disclosure
Egalet Corp
Security class unavailable · CUSIP: 28226B302
Event date: 2020-03-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 51.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-038823
- Form type
- SC 13D
- Filer
- Assertio Therapeutics, Inc
- CIK
- CIK 1005201
- Filed
- Mar 26, 2020
- Reporting period
- Mar 16, 2020
- Description
- Schedule 13D beneficial ownership